- Conditions
- Dyslipidemias, Homocystinaemia, Lipid Metabolism Disorders, +3 more
- Locations
-
Not specified
Clinical trial condition
Lipid Metabolism Disorders
Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.
3,310 public trials
329 recruiting studies
Lipid Metabolism Disorders trial results
NCT03017950
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hyperlipidemias, +5 more
- Locations
-
- Inha University Hospital Incheon, South Korea
NCT00090402
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +17 more
- Locations
-
- Oregon Health and Science University Portland, Oregon, United States
NCT02889614
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +8 more
- Locations
-
- Nantes University Hospital Nantes, France
Completed
Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
NCT02753504
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- Severance Hospital Seoul, Seodaemun-gu, South Korea
NCT02770625
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
- Locations
-
Not specified
Completed
Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
NCT03210649
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- Severance Hospital Seoul, Seodaemun-gu, South Korea
Completed
Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects
NCT03175835
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Korea University Anam Hospital Seoul, South Korea
NCT00244582
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
Completed
Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
NCT00833976
- Conditions
- Bipolar Disorder, Bipolar and Related Disorders, Dyslipidemias, +13 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States